Company: MIRA
Filing Date: 2025-06-17
Form Type: PREM14A
Source: 0001641172-25-015340
Chunk: 115

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-06-17
Form: PREM14A
Chunk 115
---
 any of the rights or obligations of a party thereto will be modified or altered or which provide for any increased payment or benefit or accelerated vesting, in any such case as a result of the execution of this Agreement and the consummation of the transactions contemplated hereby and by the other Transaction Agreements or which contain change in control provisions; (ii)which provides for any Award that would not be expired, exercised, assumed or exchanged as a result of the execution of this Agreement and the consummation of the transactions contemplated hereby and by the other Transaction Agreements; (iii)which provides for any material license or other material arrangement with respect to any Intellectual Property of SKNY; (iv)which constitutes an undertaking or agreement with any other Governmental Entity; (v)which is an arrangement limiting or restraining SKNY or any successor thereto from engaging or competing in any manner or in any business or from conducting any activity in any geographic area or from soliciting any Person to enter into a business or employment relationship or to enter into a relationship with any Person; (vi)under which SKNY makes payments in excess of One Hundred Thousand Dollars ($100,000) on an annual basis; (vii)which is a Labor Agreement or any other Contract with any labor union; (viii)which is a real property lease or a personal property lease; (ix)pursuant to which any Indebtedness is outstanding or may be incurred, including any loan or credit agreement, note, bond, mortgage, indenture, letter of credit, interest rate or currency hedging arrangement or other similar agreement or instrument or pursuant to which any Indebtedness of any Person is guaranteed by SKNY; (x)pursuant to which SKNY is required to indemnify or hold harmless any Person other than Contracts entered into in the ordinary course of business consistent with past practice; (xi)all powers of attorney or other similar agreements or grant of agency by SKNY; (xii)all Contracts involving the settlement of any Proceeding or threatened Proceeding which will (a)involve payments after the date of the Latest Balance Sheet of consideration in excess of One Hundred Thousand dollars ($100,000), or (b)impose monitoring, reporting or other continuing obligations on SKNY; (xiii)pursuant to which SKNY has made any advance, loan, extension of credit or capital contribution to, or other investment in, any Person (other than SKNY); (xiv)which is a partnership, joint venture or similar